|
LOC728190 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.880700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.135750E-02 |
| Normal-vs-Stage2 |
7.944900E-03 |
| Normal-vs-Stage3 |
1.261450E-03 |
| Normal-vs-Stage4 |
3.793800E-01 |
| Stage1-vs-Stage2 |
4.702600E-01 |
| Stage1-vs-Stage3 |
2.395800E-01 |
| Stage1-vs-Stage4 |
4.167000E-01 |
| Stage2-vs-Stage3 |
7.817400E-01 |
| Stage2-vs-Stage4 |
1.703030E-01 |
| Stage3-vs-Stage4 |
8.962100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.677300E-03 |
| Normal-vs-AfricanAmerican |
4.998000E-02 |
| Normal-vs-Asian |
1.999020E-01 |
| Caucasian-vs-AfricanAmerican |
5.257800E-01 |
| Caucasian-vs-Asian |
9.197000E-01 |
| AfricanAmerican-vs-Asian |
9.067600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.155800E-04 |
| Normal-vs-Female |
2.836000E-01 |
| Male-vs-Female |
2.055000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.770200E-02 |
| Normal-vs-Extreme_Weight |
8.592800E-04 |
| Normal-vs-Obese |
1.252050E-02 |
| Normal-vs-Extreme_Obese |
7.349800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.918400E-02 |
| Normal_Weight-vs-Obese |
5.402600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.115400E-01 |
| Extreme_Weight-vs-Obese |
2.362200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.105980E-01 |
| Obese-vs-Extreme_Obese |
2.859200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.252400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.934370E-02 |
| Normal-vs-Age(61-80Yrs) |
4.504300E-03 |
| Normal-vs-Age(81-100Yrs) |
2.220700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.068600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.459790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.196430E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.304000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.032160E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.057700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.599880E-02 |
| Normal-VS-Type2 PRCC |
4.248100E-04 |
| Normal-VS-KIRP CIMP |
8.446200E-01 |
| Normal-VS-Unclassified PRCC |
2.576400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.237900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.088200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.896200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.841500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.567400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.282170E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33249999999074E-05 |
| Normal-vs-N1 |
1.173660E-02 |
| Normal-vs-N2 |
5.066800E-01 |
| N0-vs-N1 |
2.649400E-01 |
| N0-vs-N2 |
2.059400E-01 |
| N1-vs-N2 |
5.111800E-01 |
|
|
